Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02357849 · ClinicalTrials.gov registry record · Phase 4
Fluoxetine vs Aripiprazole Comparative Trial (FACT)
A Phase 4 study, sponsored by Northwell Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT02357849: Clinical Trial Phase 4 study, sponsored by Northwell Health.
NCT02357849 is a Phase 4 study that was terminated before completion, run by Northwell Health. The registered enrollment target is 9 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02357849, a Phase 4 study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
We are conducting a randomized, 24-week, double-blind study, comparing fluoxetine with aripiprazole in 48 patients with attenuated positive symptoms at a level of at least moderate severity.
Primary Outcome
Time to either all-cause-discontinuation or need to add another psychotropic agent
Interventions
- DRUG Fluoxetine
- DRUG Aripiprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-07 |
| Est. Completion | 2022-04-04 |
| Phase | Phase 4 |
Why NCT02357849 stopped before completion
NCT02357849 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Fluoxetine is the first listed.
NCT02357849 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02357849 about?
NCT02357849 is a clinical study titled "Fluoxetine vs Aripiprazole Comparative Trial (FACT)". We are conducting a randomized, 24-week, double-blind study, comparing fluoxetine with aripiprazole in 48 patients with attenuated positive symptoms at a level of at least moderate severity.
What is the current status of trial NCT02357849?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2014-07. Estimated completion is 2022-04-04.
What interventions are being tested in trial NCT02357849?
The interventions under investigation include: Fluoxetine (DRUG), Aripiprazole (DRUG).
Who is sponsoring clinical trial NCT02357849?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02357849's enrollment target sits among peer trials
9 1968th of 2000 higher than 29 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia